[2] Sell S,Pierce G.Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers[J].Lab Invest,1994,70(1):6-22.
[2] Ginestier C,Wicinski J,Cerrera N,et al.Retinoid signaling regulates breast cancer stem cell differentiation[J].Cell Cycle,2009,8(20):3297-3302.
[3] Kim C,Dirks P.Cancer and stem cell biology:how tightly intertwined?[J].Cell Stem Cell,2008,3(2):147-150.
[4] Czitrom A,Edwards S,Phillips R,et al.The function of antigenpresenting cells in mice with severe combined immunodeficiency[J].J Immunol,1985,134(4):2276-2280.
[5] Prochazka M,Gaskins H,Shultz L,et al.The nonobese diabetic SCID mouse:model for spontaneous thymomagenesis associated with immunodeficiency[J].Proc Natl Acad Sci USA,1992,89(8):3290-3294.
[6] Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J].Nat Med,1997,3(7):730-737.
[7] Reya T,Morrison SJ,Clarke MF,et al.Stem cells,and cancer stem cells[J].Nature,2001,414(6859):105-111.
[8] AI-Hajj M,Widna M,Benito-Hernandez A,et al.Prospective identification of tumorigenic breast cancer cells[J].Proc Natl Acad Sci USA,2003,100(7):3983-3988.
[9] Ginestier C,Hur M,Charafe-Jauffret E,et al.ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome[J].Cell Stem Cell,2007,1(5):555-567.
[10] Balicki D.Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1[J].Cell Stem Cell,2007,1(5):485-487.
[11] 韩明利,吴诚义.ALDH1作为干细胞标记物的研究进展[J].生物医学工程学杂志,2010,27(5):1183-1186.
[12] Levi BP,Yilmaz OH,Duester G,et al.Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems[J].Blood,2009,113(8):1670-1680.
[13] Hess DA,Wirthlin L,Craft TP,et al.Selection based on CD133 and high aldehyde dehydrogenase activity isolates long term reconstituting human hematopoietic stem cells[J].Blood,2006,107(5):2162-2169.
[14] Chute JP,Muramoto GG,Whitesides J,et al.Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells[J].Proc Natl Acad Sci USA,2006,103(31):11707-11712.
[15] Liu G,Yuan X,Zeng Z,et al.Analysis of gene expression and chemoresistance of CD133 + cancer stem cells in glioblastoma[J].Mol Cancer,2006(5):67.
[16] Ghods AJ,Irvin D,Liu G,et al.Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells[J].Stem Cells,2007,25(7):1645-1653.
[17] Fillmore CM,Kuperwasser C.Human breast cancer cell lines contain stem-like cells that self-renew,give rise to phenotypically diverse progeny and survive chemotherapy[J].Breast Cancer Res,2008,10(2):R25.
[18] Haraguchi N,Utsunomiya T,Inoue H,et al.Characterization of a side population of cancer cells from human gastrointestinal system[J].Stem Cells,2006,24(3):506-513.
[19] Tanei T,Morimoto K,Shimazu K,et al.Association of breast cancer stem cells identified by aldehyde dehydrogenase expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers[J].Clin Cancer Res,2009,15(12):4234-4241.
[20] Gillet JP,Efferth T,Remacle J.Chemotherapy-induced resistance by ATP-binding cassette transporter genes[J].Biochim Biophys Acta,2007,775(2):237-262.
[21] Raaijmakers MH.ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute andchronic myeloid leukemia[J].Leukemia,2007,21(10):2094-2102.
[22] Dean M,Fojo T,Bates S.Tumour stem cells and drug resistance[J].Nat Rev Cancer,2005,5(4):275-284.
[23] 查郎,王子卫.肿瘤干细胞对恶性肿瘤辅助治疗的影响[J].生命科学,2010,22(8):801-805.
[24] Phoenix K,Hong X,Tannenbaum S.Expression of the cancer stem cell marker ALDHA1 in primary breast cancer:a mech-anism for chemotherapy resistance[J].Cancer Res,2009,69(24 Suppl):1135.
[25] Kelly P,Dakic A,Adams J,et al.Tumor growth need not be driven by rare cancer stem cells[J].Science,2007,317(5836):337.
[26] Adams J,Straeser A.Is tumor growth sustained by rare cancer stem cells or dominant clones[J].Cancer Res,2008,68(11):4018-4021.